Matrix Metalloproteases as Biomarkers of Disease

Area of Science:

• Biochemistry and Molecular Biology
• Cellular Biology
• Pathophysiology

Background:

• Matrix metalloproteinases (MMPs) are essential enzymes involved in numerous cellular processes, including tissue remodeling.
• Imbalances in MMP activity, often due to genetic factors or altered expression, are implicated in the development of various diseases.
• The extracellular matrix (ECM) is significantly remodeled by MMPs, highlighting their role in tissue homeostasis.

Purpose of the Study:

• To underscore the critical role of matrix metalloproteinases (MMPs) in cellular functions and disease pathogenesis.
• To highlight the significance of MMPs and their inhibitors in maintaining extracellular matrix (ECM) integrity.
• To emphasize the potential of MMPs as diagnostic and prognostic biomarkers for ECM-related diseases.

Main Methods:

• Review of existing literature on matrix metalloproteinases (MMPs) and their functions.
• Analysis of the mechanisms by which MMP dysregulation contributes to disease.
• Evaluation of MMPs as biomarkers in the context of extracellular matrix (ECM) alterations.

Main Results:

• Matrix metalloproteinases (MMPs) are vital for normal cellular processes.
• Dysfunctional MMP activity and altered MMP-inhibitor interactions are linked to disease development.
• MMPs play a key role in extracellular matrix (ECM) remodeling.

Conclusions:

• Matrix metalloproteinases (MMPs) are critical regulators of cellular processes and ECM remodeling.
• Disruptions in MMP activity are associated with the pathogenesis of numerous diseases.
• MMPs represent promising biomarkers for diagnosing and predicting outcomes of diseases involving ECM alterations.